Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. lifted its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 3.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 498,056 shares of the company’s stock after purchasing an additional 15,771 shares during the period. JPMorgan Chase & Co.’s holdings in Doximity were worth $21,700,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of the stock. MetLife Investment Management LLC boosted its position in Doximity by 0.6% during the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock worth $2,835,000 after acquiring an additional 363 shares during the last quarter. First Horizon Advisors Inc. lifted its stake in Doximity by 22.5% in the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock worth $91,000 after purchasing an additional 384 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after purchasing an additional 412 shares during the last quarter. Cornercap Investment Counsel Inc. grew its position in shares of Doximity by 3.2% in the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock valued at $479,000 after purchasing an additional 537 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its holdings in shares of Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after purchasing an additional 603 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on DOCS. Evercore ISI increased their price target on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Truist Financial lifted their target price on Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research report on Thursday, November 14th. Bank of America upped their price target on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research note on Monday. Baird R W raised Doximity to a “strong-buy” rating in a research report on Tuesday, September 17th. Finally, Robert W. Baird upped their target price on shares of Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research report on Tuesday, September 17th. Thirteen equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Doximity has an average rating of “Hold” and an average target price of $53.00.

Doximity Trading Down 1.0 %

DOCS stock opened at $54.93 on Thursday. Doximity, Inc. has a one year low of $22.96 and a one year high of $61.75. The firm has a 50-day moving average of $52.62 and a two-hundred day moving average of $41.32. The firm has a market capitalization of $10.25 billion, a PE ratio of 63.14, a P/E/G ratio of 4.16 and a beta of 1.38.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.